NBIX
Neurocrine Biosciences Inc
143.20$
+1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +64.2% | -197.3% | – | – | – | – | – | -369.3% | – | – | – | – | – | – | -101.4% | – | – | – | – | – | – | – | +45.0% | +55.4% | +12.3% | +32.3% | +14.9% | +52.7% | +31.5% | |
| – | +30.0% | +30.8% | +23.5% | +4.7% | +20.6% | +16.9% | +19.2% | +91.8% | +42.6% | +4.7% | -11.0% | -19.1% | -58.2% | -54.8% | -51.7% | -5.3% | +2.1% | +23.2% | +22.0% | +44.0% | +65.2% | +66.7% | +85.0% | +16.2% | +26.7% | +43.1% | +36.5% | +27.2% | +11.1% | |
| – | – | – | – | – | – | – | +42.8% | -68.4% | +0.0% | +2,595.1% | -30.5% | -19.9% | -30.7% | -43.4% | -6.9% | +87.8% | +24.5% | +52.3% | +173.5% | +0.3% | +49.4% | +36.6% | +29.6% | +32.8% | +34.2% | +29.0% | +12.2% | +0.6% | +11.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +51.7% | +96.2% | +250.0% | -0.1% | +61.5% | +41.8% | +32.6% | -348.1% | – | +86.4% | – | – | – | |
| – | – | -227.8% | – | -80.3% | +326.6% | +631.2% | +25.7% | -246.8% | – | -435.1% | – | -173.9% | – | – | – | – | – | -86.7% | +440.9% | -33.6% | -252.3% | – | – | – | – | -503.6% | – | -168.1% | – | |
| – | +300.0% | -42.2% | -43.2% | +16.2% | +55.9% | +39.3% | +851.7% | +5.4% | -86.4% | -57.0% | -79.9% | +111.9% | -97.4% | +800.0% | +138.1% | +29.5% | -43.9% | +195.8% | +20.0% | +112.4% | +68.9% | +257.3% | -40.7% | -25.9% | +114.7% | -29.5% | +71.5% | +35.0% | -11.0% | |
| – | – | – | -551.1% | +257.0% | -78.0% | +176.6% | +305.6% | – | -49.2% | +1,182.0% | -82.7% | +113.2% | -72.9% | -553.7% | -93.5% | +884.2% | – | -2,073.1% | +85.8% | – | -322.4% | -3.3% | -13.1% | – | -3,275.6% | +36.0% | +163.7% | -72.9% | +108.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +29,166.4% | -93.7% | +2,516.6% | +99.7% | -99.1% | +480.1% | +113.0% | -7.5% | +6.5% | -5.5% | +62.5% | -100.0% | – | -44.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -137.2% | +0.0% | +0.0% | -99.9% | +278,900.0% | -100.0% | – | -100.0% | |
| – | -98.5% | +171.4% | +2,057.9% | +129.6% | +92.6% | -96.8% | +3,532.1% | -82.6% | -71.8% | -2.4% | +466.9% | -102.5% | – | +117.0% | -98.7% | +29,166.4% | -93.7% | +2,516.6% | +99.7% | -99.1% | +21,517.0% | -94.3% | +9.8% | -587.0% | – | -955.1% | – | -845.3% | -92.1% | |
| – | -8.2% | -191.1% | – | -101.9% | – | -183.7% | – | -172.8% | – | – | -39.8% | -267.0% | – | – | -123.6% | – | -239.0% | – | – | -78.8% | +1,766.7% | -165.5% | – | – | +105.5% | -147.7% | – | – | – | |
| – | -9.8% | -413.0% | – | – | – | – | – | – | – | – | – | – | – | – | -102.9% | – | – | – | – | – | – | – | +72.7% | +64.5% | +7.1% | +38.5% | +12.0% | +54.1% | +34.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.